Immune Responses of Healthy Subjects to a Single Dose of Intramuscular Inactivated Influenza A/Vietnam/1203/2004 (H5N1) Vaccine after Priming with an Antigenic Variant
The Journal of Infectious Diseases2008Vol. 198(5), pp. 635–641
Citations Over TimeTop 10% of 2008 papers
Nega Ali Goji, Carrie Nolan, Heather Hill, Mark Wolff, Diana L. Noah, Tracy B. Williams, Thomas Rowe, John J. Treanor
Abstract
ClinicalTrials.gov identifier: NCT00240903.
Related Papers
- → Efficacy of inactivated vaccines against H5N1 avian influenza infection in ducks(2006)71 cited
- → Efficacy of Two H5N9-Inactivated Vaccines Against Challenge with a Recent H5N1 Highly Pathogenic Avian Influenza Isolate from a Chicken in Thailand(2007)38 cited
- → Development of an effective contemporary trivalent avian influenza vaccine against circulating H5N1, H5N8, and H9N2 in Egypt(2019)11 cited
- → Efficacy of Inactivated Avian Influenza H5N1 Vaccine in SPF chicken against Avian Influenza Viruses H5N2 and H5N8 (Egyptian Isolates)(2021)
- → Study of Shenzhen Quadrivalent Inactivated Influenza Vaccine Versus the Shenzhen Trivalent Inactivated Influenza Vaccine in Chinese Subjects From 6 Months of Age(2019)